Cue Biopharma announced a reboot Thursday afternoon, bringing in notable biotech executive Shao-Lee Lin as well as a new allergy asset developed in Taiwan and mainland China.
The Boston-based biotech has focused on developing T …
The FDA on Friday approved Pfizer and Arvinas’ drug vepdegestrant for patients with a certain form of breast cancer. But it’s unclear how many will
Amgen is launching three new late-stage trials for its long-acting obesity shot MariTide, including one designed to test the drug in patients switching away from
Seaport Therapeutics began trading as a public company on Friday after executives rang the Nasdaq’s opening bell. With a team largely made up of Karuna
After holding a rally in April, Samsung Biologics union workers on Friday started a five-day strike over wage negotiations. Around 95% of the company’s union
Q1 earnings recap with Endpoints News After a deal-heavy first quarter, earnings season is in full swing. We’re breaking down the news and trends from
Cue Biopharma announced a reboot Thursday afternoon, bringing in notable biotech executive Shao-Lee Lin as well as a new allergy asset developed in Taiwan and mainland China.
The Boston-based biotech has focused on developing T …